Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Hospira Inc gives FY 2014 guidance; revenue guidance below analysts' estimates


Wednesday, 12 Feb 2014 07:30am EST 

Hospira Inc:Expects the change to net sales for fiscal 2014 to range between negative 2 and positive 3 percent on a constant-currency basis, with a flat to negative 1 percent impact from foreign currency.Expects fiscal 2014 adjusted diluted earnings per share (EPS) for fiscal 2014 to be in a range of $2.00 to $2.25.Reported revenue of $4.003 billion in fiscal 2013.Fiscal 2014 revenue of $4.159 billion - Thomson Reuters I/B/E/S.Fiscal 2014 EPS of $2.15 - Thomson Reuters I/B/E/S. 

Company Quote

62.66
0.22 +0.35%
19 Dec 2014